Blood Cancer Center

  • News
Multiple Myeloma Rx Gets New Formulation
The US Food and Drug Administration (FDA) has approved a new formulation of a drug that treats a type of blood cancer.
New Blood Cancer Rx Gets FDA Nod
The US Food and Drug Administration (FDA) has approved a new medication to treat multiple myeloma.
New Rx Approvals
The US Food and Drug Administration (FDA) has approved five medications in the last month.
A New Treatment for a Rare Blood Cancer
The US Food and Drug Administration (FDA) has approved the first treatment for a rare type of blood cancer.
New Lymphoma Rx Approved
The US Food and Drug Administration (FDA) has approved a medication to treat adults with mantle cell lymphoma.
Second US Gene Therapy Approved
The US Food and Drug Administration (FDA) has approved the United States' second gene therapy to treat certain types of lymphoma.
New Lymphoma Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new treatment for a type of non-Hodgkin lymphoma.
First-Ever Gene Therapy Approved in US
The US Food and Drug Administration (FDA) has approved the first gene therapy in the United States.
Leukemia Rx Gets FDA Approval
The US Food and Drug Administration (FDA) has approved a new medication to treat acute myeloid leukemia.
New Leukemia Treatment Gets Green Light
The US Food and Drug Administration (FDA) has approved a new treatment for a certain type of leukemia.
A New Combo Rx to Fight Leukemia
The US Food and Drug Administration (FDA) has approved a new medication to treat a certain type of leukemia.
New Leukemia Rx Approved
The US Food and Drug Administration (FDA) has approved a new medication to treat leukemia.
New Rx Treats Common Blood Cancer
The US Food and Drug Administration (FDA) has approved a new medication to treat a common type of blood cancer.
Boosting Leukemia Survival
Umbilical cord blood transplants may lead to high survival in patients with leukemia who are at high risk for relapse post-transplant, a new study found.
A New Job for Opdivo
The US Food and Drug Administration (FDA) has approved a new treatment for Hodgkin lymphoma.
Targeted Leukemia Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved the first treatment to specifically target the B-cell lymphoma 2 (BCL-2) protein found in patients with chronic lymphocytic leukemia (CLL).
A New Formulation for Melphalan
The US Food and Drug Administration (FDA) approved a new formula of melphalan under the brand name Evomela to treat patients with multiple myeloma.
New Treatment Offers Hope for Multiple Myeloma
Multiple myeloma is a hard cancer to cure. But there may be some good news on that front.
Cancer Forecast: Leukemia on the Decline in 2016
According to new predictions, 2016 will be a good year for leukemia.
New Leukemia Rx Gets FDA Nod
Doctors may now have another tool in their arsenal for the treatment of chronic lymphocytic leukemia (CLL).
More